Update on Challenger Limited!

challenger ltd

Mixed Updates: Challenger Limited (ASX: CGF) has recently announced allotment of additional shares to CEO Brian Benari. As per the filing, transfer of 634,843 shares was done. With the latest allotment, Benari continues to hold the shares more than the Company’s minimum shareholding requirements. In another development, the Challenger board welcomed Duncan West to the company’s board of directors. Mr. West would be an independent non-executive director of Challenger Limited and Challenger Life Company Limited.

Challenger Limited recently announced a change of its substantial holding in the Vocus Group Limited. Under the current arrangement, the voting power of Challenger Limited in Vocus Group Limited stands at 8.61%. Further, UBS Group AG and its related bodies corporate became the substantial holders in Challenger Limited with the increased voting power of 5.16%. The company has altered its interest in Monadelphous Group Limited by increasing the voting power to 7.65% compared to previous 6.55%. Challenger Limited also furnished the details of its substantial holdings in Think Childcare Limited and according to the latest filing, the voting power now stands at 5.12%. [optin-monster-shortcode id=”wxhmli4jjedneglg1trq”]

The company posted total comprehensive income for the year after tax at $323.8 Mn in FY18 compared to $398.2 Mn in FY17. Diluted Earnings per share also came in lower at 52.2 cents in FY18 compared to 67.8 cents in FY17. The company recorded higher Net cash inflows from the operating activities at $1,977.4 Mn in FY18 compared to $1,597.2 Mn in FY17. Challenger Life is a market leader in Australian retirement incomes, having 73% annuity market share. It has also built an annuity relationship with Mitsui Sumitomo Primary Life Insurance Company Limited, a leader in offering the Australian dollar-denominated annuities in Japan.

Meanwhile, the share price has fallen 19.36 percent in the past three months as at September 12, 2018 and traded at reasonable PE of 19.20x. CGF’s shares traded at a current market price of $ 10.240 with the market capitalization of circa $ 6.33 Bn as of September 13, 2018.

Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


Disclaimer

The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkinemedia.com and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.


6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report